LIAN230221
2021-08-17
Please like this and comment thanks
Buffett's Berkshire pares drug holdings, sheds Axalta, Biogen
免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP，发表看法
APP内打开
发表看法
1
1
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":839688341,"tweetId":"839688341","gmtCreate":1629156672383,"gmtModify":1631893546830,"author":{"id":3577137894024224,"idStr":"3577137894024224","authorId":3577137894024224,"authorIdStr":"3577137894024224","name":"LIAN230221","avatar":"https://static.tigerbbs.com/2e67ec99c7595bec06dd19e19f03d461","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":16,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Please like this and comment thanks </p></body></html>","htmlText":"<html><head></head><body><p>Please like this and comment thanks </p></body></html>","text":"Please like this and comment thanks","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/839688341","repostId":2160278089,"repostType":4,"repost":{"id":"2160278089","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1629154978,"share":"https://www.laohu8.com/m/news/2160278089?lang=&edition=full","pubTime":"2021-08-17 07:02","market":"us","language":"en","title":"Buffett's Berkshire pares drug holdings, sheds Axalta, Biogen","url":"https://stock-news.laohu8.com/highlight/detail?id=2160278089","media":"Reuters","summary":"Aug 16 (Reuters) - Warren Buffett's Berkshire Hathaway Inc said on Monday it trimmed or eliminated i","content":"<p>Aug 16 (Reuters) - Warren Buffett's Berkshire Hathaway Inc said on Monday it trimmed or eliminated its stakes in several pharmaceutical companies, and reported a small new stake in a Merck & Co spinoff, Organon & Co.</p>\n<p>In the second quarter, Berkshire said it exited a $180 million stake in Biogen Inc and reduced investments in Abbvie Inc, Bristol-Myers Squibb Co and Merck.</p>\n<p>It also shed a $411 million stake in paint maker Axalta Coating Systems Ltd, a Berkshire holding since 2015.</p>\n<p>The changes were disclosed in a regulatory filing detailing Berkshire's U.S.-listed holdings as of June 30.</p>\n<p>Berkshire has been a net seller of stocks in 2021, including in the second quarter when it sold $1.1 billion more stocks than it bought.</p>\n<p>That suggests Buffett and his investment managers Todd Combs and Ted Weschler remain wary of valuations as stock prices regularly set new highs.</p>\n<p>The Standard & Poor's has doubled from its March 2020 trough early in the COVID-19 pandemic.</p>\n<p>Berkshire has instead bought back about $14.3 billion of its own stock between January and late July though its share price also set records, and now sits just 2% below its May 7 peak.</p>\n<p>The Omaha, Nebraska-based conglomerate ended June with $144.1 billion of cash and equivalents. Berkshire also owns dozens of businesses including the BNSF railroad, Geico auto insurance and Dairy Queen ice cream.</p>\n<p>Organon specializes in contraception and other women's health products, and has dozens of brands in other fields.</p>\n<p>Berkshire reported a $46.9 million Organon stake as of June 30.</p>\n<p>Its largest investments on that date were $124.3 billion in Apple Inc and $42.6 billion in $Bank of America Corp(BAC-N)$.</p>\n<p>In Monday's filing, Berkshire also reported lowered stakes in Chevron Corp, General Motors Co, media company Liberty Global Plc, insurance broker Marsh & McLennan Cos and US Bancorp.</p>\n<p>It reported increased stakes in supermarket chain Kroger Co, home furnishings chain RH and Marsh rival Aon Plc, which under regulatory pressure called off a $30 billion merger with Willis Towers Watson Plc last month.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Buffett's Berkshire pares drug holdings, sheds Axalta, Biogen</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBuffett's Berkshire pares drug holdings, sheds Axalta, Biogen\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-08-17 07:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Aug 16 (Reuters) - Warren Buffett's Berkshire Hathaway Inc said on Monday it trimmed or eliminated its stakes in several pharmaceutical companies, and reported a small new stake in a Merck & Co spinoff, Organon & Co.</p>\n<p>In the second quarter, Berkshire said it exited a $180 million stake in Biogen Inc and reduced investments in Abbvie Inc, Bristol-Myers Squibb Co and Merck.</p>\n<p>It also shed a $411 million stake in paint maker Axalta Coating Systems Ltd, a Berkshire holding since 2015.</p>\n<p>The changes were disclosed in a regulatory filing detailing Berkshire's U.S.-listed holdings as of June 30.</p>\n<p>Berkshire has been a net seller of stocks in 2021, including in the second quarter when it sold $1.1 billion more stocks than it bought.</p>\n<p>That suggests Buffett and his investment managers Todd Combs and Ted Weschler remain wary of valuations as stock prices regularly set new highs.</p>\n<p>The Standard & Poor's has doubled from its March 2020 trough early in the COVID-19 pandemic.</p>\n<p>Berkshire has instead bought back about $14.3 billion of its own stock between January and late July though its share price also set records, and now sits just 2% below its May 7 peak.</p>\n<p>The Omaha, Nebraska-based conglomerate ended June with $144.1 billion of cash and equivalents. Berkshire also owns dozens of businesses including the BNSF railroad, Geico auto insurance and Dairy Queen ice cream.</p>\n<p>Organon specializes in contraception and other women's health products, and has dozens of brands in other fields.</p>\n<p>Berkshire reported a $46.9 million Organon stake as of June 30.</p>\n<p>Its largest investments on that date were $124.3 billion in Apple Inc and $42.6 billion in $Bank of America Corp(BAC-N)$.</p>\n<p>In Monday's filing, Berkshire also reported lowered stakes in Chevron Corp, General Motors Co, media company Liberty Global Plc, insurance broker Marsh & McLennan Cos and US Bancorp.</p>\n<p>It reported increased stakes in supermarket chain Kroger Co, home furnishings chain RH and Marsh rival Aon Plc, which under regulatory pressure called off a $30 billion merger with Willis Towers Watson Plc last month.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GM":"通用汽车","CVX":"雪佛龙","BIIB":"渤健公司","LBTYA":"自由全球","BRK.A":"伯克希尔","KR":"克罗格","ABBV":"艾伯维公司","AON":"怡安保险","RH":"Restoration Hardware Holdings","MRK":"默沙东","OGN":"Organon & Co","BRK.B":"伯克希尔B","AXTA":"艾仕得涂料系统","BMY":"施贵宝","MMC":"威达信集团"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2160278089","content_text":"Aug 16 (Reuters) - Warren Buffett's Berkshire Hathaway Inc said on Monday it trimmed or eliminated its stakes in several pharmaceutical companies, and reported a small new stake in a Merck & Co spinoff, Organon & Co.\nIn the second quarter, Berkshire said it exited a $180 million stake in Biogen Inc and reduced investments in Abbvie Inc, Bristol-Myers Squibb Co and Merck.\nIt also shed a $411 million stake in paint maker Axalta Coating Systems Ltd, a Berkshire holding since 2015.\nThe changes were disclosed in a regulatory filing detailing Berkshire's U.S.-listed holdings as of June 30.\nBerkshire has been a net seller of stocks in 2021, including in the second quarter when it sold $1.1 billion more stocks than it bought.\nThat suggests Buffett and his investment managers Todd Combs and Ted Weschler remain wary of valuations as stock prices regularly set new highs.\nThe Standard & Poor's has doubled from its March 2020 trough early in the COVID-19 pandemic.\nBerkshire has instead bought back about $14.3 billion of its own stock between January and late July though its share price also set records, and now sits just 2% below its May 7 peak.\nThe Omaha, Nebraska-based conglomerate ended June with $144.1 billion of cash and equivalents. Berkshire also owns dozens of businesses including the BNSF railroad, Geico auto insurance and Dairy Queen ice cream.\nOrganon specializes in contraception and other women's health products, and has dozens of brands in other fields.\nBerkshire reported a $46.9 million Organon stake as of June 30.\nIts largest investments on that date were $124.3 billion in Apple Inc and $42.6 billion in $Bank of America Corp(BAC-N)$.\nIn Monday's filing, Berkshire also reported lowered stakes in Chevron Corp, General Motors Co, media company Liberty Global Plc, insurance broker Marsh & McLennan Cos and US Bancorp.\nIt reported increased stakes in supermarket chain Kroger Co, home furnishings chain RH and Marsh rival Aon Plc, which under regulatory pressure called off a $30 billion merger with Willis Towers Watson Plc last month.","news_type":1},"isVote":1,"tweetType":1,"viewCount":41,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":30,"xxTargetLangEnum":"ORIG"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/839688341"}
精彩评论